Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Reduced price
Medicares Prescription Drug Program: Competition Issues & Cost Trends

Medicares Prescription Drug Program: Competition Issues & Cost Trends

9781634631228
724.44 zł
651.99 zł Save 72.45 zł Tax included
Lowest price within 30 days before promotion: 651.99 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DHL, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (generally referred to as the Medicare Modernization Act, or MMA) substantially expanded the federal Medicare program by creating the prescription drug benefit known as Part D. In fiscal year 2013, Medicare Part D covered 39 million people. The federal government spent $59 billion net of premiums on Part D in that year; after accounting for certain payments from states under the program, the net federal cost was $50 billion, which represented 10 percent of net federal spending for Medicare. This book discusses the cost trends and competition issues of Medicares Prescription Drug Program.
Product Details
Nova Science Publishers Inc
74726
9781634631228
9781634631228

Data sheet

Publication date
2014
Issue number
1
Cover
hard cover
Pages count
100
Dimensions (mm)
155.00 x 230.00
Weight (g)
330
  • Preface; Competition & the Cost of Medicares Prescription Drug Program; Effects of Using Generic Drugs on Medicares Prescription Drug Spending; Spending Patterns for Prescription Drugs Under Medicare Part D; Index.
Comments (0)
Viewed products

  • Frequently purchased together

    No products available